Shutterfly (SFLY) and American Greetings (AM) derive signicant revenues from letting consumers print their greeting cards. Apple (AAPL) has just introduced an app that allows consumers to print greeting cards. We expect similar apps to proliferate on Android and Windows. This is a negative development for Shutterfly
VirnetX Holding Corporation (VHC) stock is dropping on patent reexamination news. United States Patent and Trademark Office website has ordered a reexamination for application number 95/100,682 regarding patents entitled “Agile Network Protocol for Secure Communications with Assured System Availability,” which is assigned to VirnetX (VHC). Previously Apple (AAPL) filed a
Taken more profits on Pan American Silver (PAAS) on a 5% tranche at $26.52. If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Short Sell Change Alert.
It is time to take profits on Brent crude (BZ) (USO) right here at $103.05. In ZYX Short Sell Change Alert continue to hold a spread position between Brent crude and West Texas intermediate for much larger gains to come.
Our position Adobe Systems (ADBE) has been hurt because certain Apple (AAPL) devices do not support Flash. Amazon (AMZN) has released its new Silk browser. Silk supports Flash. This is good for Adobe. We will be closely following these three stocks on the ZYX Buy Change
Research In Motion (RIMM) is moving up strongly on speculation that Carl Ichan will take a stake in Research In Motion. If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Buy Change
Corrections Corporation of America (CXW) has moved up on recommendation by Jim Cramer. The thesis propounded by Jim Cramer on Corrections Corporation of America is not wrong, but it is already priced into the stock. The stock should be sold into strength. If and
The Geo Group (GEO) has moved up on recommendation by Jim Cramer. The thesis propounded by Jim Cramer on The Geo Group is not wrong, but it is already priced into the stock. The stock should be sold into strength. If and when six screens of
ImmunoGen (IMGN ) stock has moved up sharply on the news that T-DM1 produced by ImmunoGen improved survival in patients suffering from HER2-Positive Metastatic Breast Cancer. T-DM1 contains DM1 cancer cell killing agent produced by ImmunoGen attached to an HER-2 targeting antibody. This development is mostly already in the stock
Freescale Semiconductor (FSL) reduced its Q3 revenue guidance. Freescale now projects $1.13 – $1.15 billion compared to consensus of $1.19 billion. Our analysis shows that this short fall is more likely company specific although Freescale in its statement blamed industry demand. If and when six screens